Condition:
This study attempts to examine genetic influences on the effects of tetrahydrocannabinol (Δ9-THC), the active ingredient of marijuana, cannabis, "ganja", or "pot".
Dates: July 2007 -
Study Status: Recruiting
Ages Eligible: 18 Years - 55 Years
Gender Eligible: Both
This trial accepts healthy volunteers
Inclusion Criteria:
- 18 and 55 years (extremes included) on the day of the first dosing.
Exclusion Criteria:
- Cannabis naïve individuals.
Sponsors:
Phase: Phase 1
First Received: May 13, 2008
Last Updated: August 11, 2010
Clinicaltrials.gov ID:
NCT00678730
Study HIC # 0706002754
Condition:
Intervention: Drug: delta 9 tetrahydrocannabinol
This study attempts to examine genetic influences on the effects of tetrahydrocannabinol (Δ9-THC), the active ingredient of marijuana, cannabis, "ganja", or "pot".
Dates: July 2007 -
Study Status: Recruiting
Ages Eligible: 18 Years - 55 Years
Gender Eligible: Both
Inclusion Criteria:
- 18 and 55 years (extremes included) on the day of the first dosing.
Exclusion Criteria:
- Cannabis naïve individuals.
Sponsors:
Phase: Phase 1
First Received: May 13, 2008
Last Updated: August 11, 2010
Clinicaltrials.gov ID:
NCT00678730
Study HIC # 0706002754
Jacqueline P Elander, B.A.
2039325711 Ext. 4523
jacqueline.elander@yale.edu
D'Souza, Deepak C.
Principal Investigator
HIC # 0805003779
©
Yale School of Medicine
Privacy policy Site editor
Previous